ZOLINZA (Vorinostat) Capsules
Description of Zolinza (Vorinostat)
Zolinza (Brentuximab Vedotin) is a prescription medicine used to treat a type of cancer called cutaneous T-cell lymphoma (CTCL) in patients when the CTCL gets worse, does not go away, or comes back after treatment with other medicines.
Its use and Indications
Zolinza is indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies
For treatment related information, please consult your treating Physician.
Zolinza capsules, 100 mg, are white, opaque hard gelatine capsules. Each bottle contains 120 capsules.
Storage and handling
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
M/s Merck Inc
Mob No: +91 7738100125, +91 7738151650
E Mail: firstname.lastname@example.org